{
    "SPADE_N_15591": {
        "Sequence Information": {
            "Peptide Name": "Laxaphycin A",
            "Sequence": "XXXXXFLIXLG",
            "Sequence Length": 11,
            "Biological Activity": [
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "",
            "Source": "1. Anabaena laxa\n2. Anabaena torulosa",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Total structure and inhibition of tumor cell proliferation of laxaphycins",
                    "Pubmed ID": "17323939",
                    "Reference": "J Med Chem. 2007;50:1266-1279",
                    "Author": "Bonnard I, Rolland M, Salmon JM, Debiton E, Barthomeuf C, Banaigs B",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17323939"
                },
                {
                    "Title": "Structure and biological evaluation of new cyclic and acyclic laxaphycin-A type peptides",
                    "Pubmed ID": "30929947",
                    "Reference": "Bioorg Med Chem. 2019;27:1966-1980",
                    "Author": "Bornancin L, Alonso E, Alvariño R, Inguimbert N, Bonnard I, Botana LM, Banaigs B",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30929947"
                }
            ],
            "SPADE ID": "SPADE_N_15591",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_15322",
                    "Similarity": 1.0,
                    "Sequence": "ILVPPFFLI"
                },
                {
                    "SPADE_ID": "SPADE_UN_00202",
                    "Similarity": 1.0,
                    "Sequence": "MDFWLVCYDVRDDKRRRKLAKLLEQRCQRVQYSVFECPLPEKVLTDLLHRRWLKELNLKEDSLRAYPLQRQSRSQAKIFGSPDLYEPPDFLIL"
                },
                {
                    "SPADE_ID": "SPADE_UN_18280",
                    "Similarity": 1.0,
                    "Sequence": "KEADIHFLI"
                }
            ],
            "Hemolytic Activity": "Human fibroblasts:IC50=>20 µM,Mouse fibroblasts L929:IC50=>20 µM",
            "Target Organism": "Human ovarian carcinoma PA1(IC50=>20µM),Human lung carcinoma A549(IC50=>20µM),Human metastatic malignant melanoma M4Beu(IC50=>20µM),Human breast adenocarcinoma MCF-7(IC50=>20µM),Human colon adenocarcinoma DLD-1(IC50=>20µM),Human prostate adenocarcinoma PC-3(IC50=>20µM),Human lymphoblastic leukemia CCRF-CEM(IC50=>20µM),Human lymphoblastic leukemia CCRF-CEM/VM-1(IC50=>20µM),Human lymphoblastic leukemia CCRF-CEM/VLB100(IC50=>20µM),Human neuroblastoma SH-SY5Y(no activity data)"
        }
    }
}